On March 21, 2025, Elevai Labs Inc. entered into a securities purchase agreement for a direct offering of 129,145 shares and pre-funded warrants, raising approximately $1.25 million for general corporate purposes and potential acquisitions. Additionally, on March 26, 2025, they held a Special Shareholders Meeting where several proposals were voted on, including the approval of new shares and amendments to the bylaws, with mixed results.